Children

More than 1,000 healthcare professionals involved in e-training on infection prevention and control and antimicrobial stewardship in Europe’s paediatric population

2025

The final training phase through an innovative e-learning platform involving more than 1,000 healthcare workers from Spain, Italy and Greece has just been launched after a successful pilot phase in terms of users’ engagement and satisfaction.

Read More

READI project launches to enhance patient representativeness and inclusion in European clinical research 

2025

16 January, 2025 — The pioneering project READI — Research in Europe and Diversity Inclusion — a public-private partnership funded by the Horizon Europe Innovative Health Initiative (IHI) and driven by meaningful co-leadership with patients,

Read More

UNIVERSAL project enrols first patient in trial to simplify HIV treatment in children 

2025

A significant milestone has been reached in the fight against paediatric HIV with the enrolment of the first participants in the UNIVERSAL1 trial. This achievement is a testament to the tremendous effort and dedication of the site staff in Uganda and Zimbabwe. 

Read More

A generation at risk, the AMR threat to children in Africa

2024

Antimicrobial resistance (AMR), as defined by the WHO, occurs when bacteria, viruses, fungi, and parasites no longer respond to medications. This is a growing global health crisis because AMR makes infections harder to treat and increases the risk of disease spread,

Read More

Second edition of our “PentaTr@ining 2024: Fungal Infections in Paediatrics course” launches

2024

On 16th September, 2024 we kicked off the second edition of our online course, “Fungal Infections in Paediatrics” on our PentaTr@ining platform,

Read More

Advancing health equity through inclusive clinical trials

2024

In healthcare, inclusivity is not just a moral imperative, it is also a strategic necessity for achieving widespread immunity to infections and diseases, like COVID-19, and advancing public health outcomes.

Read More

UNIVERSAL data supports Laurus Labs US FDA submission for approval of novel protease inhibitor

2024

Laurus Labs has submitted an application to the US Food and Drug Administration (FDA) for the tentative approval of paediatric Darunavir/ritonavir (pDRV/r (120/20 mg)). UNIVERSAL is the first product development project from the World Health Organisation’s (WHO) GAP-F project which was established to promote the development of safer,

Read More

It’s time for action: Protect children and pregnant people from Hepatitis 

2024

This World Hepatitis Day, with the theme “It’s Time for Action,” let’s turn our focus to underserved and often overlooked populations in the fight against this preventable disease, children and pregnant people. 

Read More

PediCAP trial findings disseminated to Mozambican healthcare community

2024

The PediCAP trial team is pleased to announce the successful completion of a series of dissemination meetings aimed at sharing trial results with key stakeholders in Mozambique. These meetings targeted a diverse audience,

Read More

Four-day antibiotic treatment shows promise for childhood pneumonia in Africa

2024

The PediCAP consortium, a global partnership of 14 institutions, presented promising results from its main trial, PediCAP-A, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) conference held from April 27-30,

Read More

Future-proofing children’s health through immunisation  

2024

This World Immunisation Week, Penta – Child Health Research proudly recognises 50 years of progress in child immunisation and the power of vaccines in protecting preventable diseases. Vaccination programs worldwide have saved millions of children’s lives and continue to be a powerful tool for promoting global health equity. 

Read More

The UNIVERSAL project’s potential impact on the health of children living with HIV, told by Dr Vivian Mumbiro

2023

In recent years, advancements in medical research have paved the way for an array of treatment options for children living with HIV. The efforts of scientists and researchers globally, have led to continuous refinement and improvement of existing regimens.

Read More

SMILE once-daily regimen non-inferior to triple ART regimen

2023

Findings from the Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (PENTA-17) trial, simply known as SMILE, were published in eClinicalMedicine on 2 June 2023.

Read More

World AIDS Day 2022: Is HIV cure attainable in our lifetime?

2022

In the lead-up to #WorldAIDSDay2022, people wonder, is an HIV cure attainable in our lifetime?

Yes, we believe there are good reasons to be optimistic about a cure:

  • The advances in treatment
  • Better access to therapy
  • Early initiation of effective antiretroviral treatment
  • Increasing numbers of children living with HIV who are surviving into adolescence and beyond
  • Reported cases of people living with HIV with a viral reservoir to a level that allowed maintenance of remission even after treatment interruption.
Read More

Penta investigates cases of acute hepatitis of unknown origin in children

2022

On 12 May, a Rapid Communication on the reported increase of acute hepatitis of unknown origin in children was published in Eurosurveillance. The paper outlines the extent and geographical distribution of these unexplained paediatric hepatitis cases in Europe and beyond.

Read More

🇬🇧 VERDI project launches

2021

Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants

The University of Padua and Penta Foundation are leaders of VERDI,

Read More

World Pneumonia Day 2021: Every breath counts

2021

It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives that are lost daily to chest infections (pneumonia).

Read More

ODYSSEY trial wins 2021 Hector Award

2021

It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf of the ODYSSEY trial team!

Read More
1 2